Presentation, Diagnosis, and Management of Enterovirus Infections in Neonates

Pediatric Drugs

Volumn 6, Issue 1, 2004, Pages 1-10

  Abzug, Mark J ^a,b  

^a University of Colorado Denver and Children s Hospital Colorado   (United States)

^b CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; CYTOCHROME P450 3A4; IMMUNOGLOBULIN; INTERFERON; NUCLEIC ACID; PLECONARIL; VIRUS VACCINE; NEUTRALIZING ANTIBODY;

ANOREXIA; ANTIBODY DETECTION; ANTIVIRAL ACTIVITY; BLOOD CLOTTING DISORDER; CELL ADHESION; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COXSACKIE VIRUS B; DIARRHEA; DISEASE SEVERITY; DRUG BIOAVAILABILITY; DRUG POTENCY; DRUG TOLERABILITY; ECHO VIRUS; ENTEROVIRUS; FEVER; HEADACHE; HEPATITIS; HUMAN; IMMUNOGLOBULIN PRODUCTION; IRRITABILITY; LETHARGY; MAJOR CLINICAL STUDY; MENINGOENCEPHALITIS; MENSTRUATION DISORDER; META ANALYSIS; MORTALITY; MULTIPLE ORGAN FAILURE; MYOCARDITIS; NAUSEA; NEWBORN; NEWBORN INFECTION; ORAL CONTRACEPTION; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PICORNAVIRUS; PNEUMONIA; POLYMERASE CHAIN REACTION; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; RECEPTOR BINDING; REVIEW; RHINOVIRUS; RISK FACTOR; SENSITIVITY ANALYSIS; SEPSIS; SEROTYPING; SIDE EFFECT; SURVIVAL; SYMPTOMATOLOGY; TISSUE CULTURE; UPPER RESPIRATORY TRACT INFECTION; VIREMIA; VIRUS CELL INTERACTION; VIRUS CULTURE; VIRUS INFECTION; VIRUS ISOLATION; VIRUS MENINGITIS; DIAGNOSTIC ACCURACY; DISEASE COURSE; ENTEROVIRUS INFECTION; MENINGITIS; NEWBORN SEPSIS; SENSITIVITY AND SPECIFICITY; SEROTYPE; SYMPTOM; VIRUS MYOCARDITIS; VIRUS PNEUMONIA;

ADULT; ANTIVIRAL AGENTS; CHILD; ENTEROVIRUS INFECTIONS; HUMANS; INFANT, NEWBORN; OXADIAZOLES; RANDOMIZED CONTROLLED TRIALS; VIRAL VACCINES;

EID: 1542377338     PISSN: 11745878     EISSN: None     Source Type: Journal    
DOI: 10.2165/00148581-200406010-00001     Document Type: Review

References (124)

1. Abzug MJ, Rotbart HA. Enterovirus infections of neonates and infants. Semin Pediatr Infect Dis 1999; 10: 169-76
2. Modlin JF. Introduction to picornaviridae. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. Philadelphia (PA): Churchill Livingstone, 2000: 1888-95
3. King AMP, Brown F, Christian P, et al. Picornaviridae. In: Wickner RB, editor. Classification and nomenclature of viruses: seventh report of the international committee on taxonomy of viruses. New York (NY): Academic Press, 1999: 657-64
4. Modlin JF. Coxsackieviruses, echoviruses, and newer enteroviruses. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. Philadelphia (PA): Churchill Livingstone, 2000: 1904-19
5. Abzug MJ, Levin MJ, Rotbart HA. Profile of enterovirus disease in the first two weeks of life. Pediatr Infect Dis J 1993; 12: 820-4
6. Modlin JF. Perinatal echovirus infection: insights from a literature review of 61 cases of serious infection and 16 outbreaks in nurseries. Rev Infect Dis 1986; 8: 918-26
7. Jenista JA, Powell KR, Menegus MA. Epidemiology of neonatal enterovirus infection. J Pediatr 1984; 104: 685-90
8. Kaplan MH, Klein SW, McPhee J, et al. Group B coxsackievirus infections in infants younger than three months of age: a serious childhood illness. Rev Infect Dis 1983; 5: 1019-32
9. Lake AM, Lauer BA, Clark JC, et al. Enterovirus infections in neonates. J Pediatr 1976; 89: 787-91
10. Modlin JF. Fatal echovirus 11 disease in premature neonates. Pediatrics 1988; 66: 775-80
11. Birenbaum E, Handsher R, Kuint J, et al. Echovirus type 22 outbreak associated with gastro-intestinal disease in a neonatal intensive care unit. Am J Perinatol 1997; 14: 469-73
12. Theodoridou M, Kakourou T, Laina I, et al. Vesiculopapular rash as a single presentation in intrauterine coxsackie virus infection. Eur J Pediatr 2002; 16: 412-3
13. Sauerbrei A, Gluck B, Jung K, et al. Congenital skin lesions caused by intrauterine infections with coxsackievirus B3. Infection 2000 Sep; 28: 326-8
14. Verboon-Maciolek MA, Krediet TG, van Loon AM, et al. Epidemiological survey of neonatal non-polio enterovirus infection in The Netherlands. J Med Virol 2002; 66: 241-5
15. Kibrick S, Benirschke K. Severe generalized disease (encephalohepatomyocarditis) occurring in the newborn period and due to infection with coxsackie virus, group B: evidence of intrauterine infection with this agent. Pediatrics 1958; 22: 857-74
16. Rorabaugh ML, Berlin LE, Heldrich F, et al. Aseptic meningitis in infants younger than 2 years of age: acute illness and neurologic complications. Pediatrics 1993; 92: 206-11
17. Haddad J, Messer J, Gut JP, et al. Neonatal echovirus encephalitis with white matter necrosis. Neuropediatrics 1990; 21: 215-7
18. Goren A, Kaplan M, Glaser J, et al. Chronic neonatal coxsackie myocarditis. Arch Dis Child 1989; 64: 404-6
19. Hornung TS, Bernard EJ, Howman-Giles RB, et al. Myocardial infarction complicating neonatal enterovirus myocarditis. J Paediatr Child Health 1999; 35: 309-12
20. Shah SS, Hellenbrand WE, Gallagher PG. Atrial flutter complicating neonatal coxsackie B2 myocarditis. Pediatr Cardiol 1998; 19: 185-6
21. Rigourd V, Dommergues MA, Ayachi A, et al. Neonatal enterovirus myocarditis. Arch Pediatr 2002; 9: 495-8
22. Baker DA, Phillips CA. Maternal and neonatal infection with coxsackievirus. Obstet Gynecol 1980; 55: 12-15S
23. Boyd MT, Jordan SW, Davis LE. Fatal pneumonitis from congenital echovirus type 6 infection. Pediatr Infect Dis J 1987; 6: 1138-9
24. Cheeseman SH, Hirsch MS, Keller EW, et al. Fatal neonatal pneumonia caused by echovirus type 9. Am J Dis Child 1977; 131: 1169
25. Abzug MJ. The prognosis for neonates with enterovirus hepatitis and coagulopathy. Pediatr Infect Dis J 2001 Aug; 20: 758-63
26. Wang J, Atchison RW, Walpusk J, et al. Echovirus hepatic failure in infancy: report of four cases with speculation on the pathogenesis. Pediatr Dev Pathol 2001; 4: 454-60
27. Abzug MJ, Johnson SM. Catastrophic intracranial hemorrhage complicating perinatal viral infections. Pediatr Infect Dis J 2000; 19: 556-9
28. Ventura KC, Hawkins H, Smith MB, et al. Fatal neonatal echovirus 6 infection: autopsy case report and review of the literature. Mod Pathol 2001; 14: 85-90
29. Barre V, Marret S, Mendel I, et al. Enterovirus-associated haemophagocytic syndrome in a neonate. Acta Paediatr 1998; 87: 469-71
30. Tarcan A, Ozbek N, Gurakan B. Bone marrow failure with concurrent enteroviral infection in a newborn. Pediatr Infect Dis 2001 Jul; 20: 719-21
31. Spector SA, Straube RC. Protean manifestations of perinatal enterovirus infections. West J Med 1983; 138: 847-51
32. Hoi-shan Chan S, Lun KS. Ventricular aneurysm complicating neonatal coxsackie B4 myocarditis. Pediatr Cardiol 2001; 22: 247-9
33. Konen O, Rathaus V, Bauer S, et al. Progressive liver calcifications in neonatal coxsackievirus infection. Pediatr Radiol 2000; 30: 343-5
34. Farmer K, MacArthur BA, Clay MM. A follow-up study of 15 cases of neonatal meningoencephalitis due to coxsackie virus B5. J Pediatr 1975; 87: 568-71
35. Sells CJ, Carpenter RL, Ray CG. Sequelae of central-nervous-system enterovirus infections. N Engl J Med 1975; 293: 1-4
36. Wilfert CM, Thompson RJ, Sunder TR, et al. Longitudinal assessment of children with enteroviral meningitis during the first three months of life. Pediatrics 1981; 67: 811-5
37. Bergman I, Painter MJ, Wald ER, et al. Outcome in children with enteroviral meningitis during the first year of life. J Pediatr 1987; 110: 705-9
38. Rantakallio P, Saukkonen AL, Krause U. Follow-up study of 17 cases of neonatal coxsackie B5 meningitis and one with suspected myocarditis. Scand J Infect Dis 1970; 2: 25-8
39. Rorabaugh ML, Berlin LE, Rosenberg L, et al. Absence of neurodevelopmental sequelae from aseptic meningitis [abstract]. Pediatr Res 1992; 31: 177A
40. Brown GC, Karunas RS. Relationship of congenital anomalies and maternal infection with selected enteroviruses. Am J Epidemiol 1971; 95: 207-17
41. Cherry JD, Soriano F, Jahn CL. Search for perinatal viral infection: a prospective clinical, virologic, and serologic study. Am J Dis Child 1968; 116: 245-50
42. Dagan R, Hall CB, Powell KR, et al. Epidemiology and laboratory diagnosis of infection with viral and bacterial pathogens in infants hospitalized for suspected sepsis. J Pediatr 1989; 115: 351-6
43. Rosenlew M, Stenvik M, Roivainen M, et al. A population-based prospective survey of newborn infants with suspected systemic infection: occurrence of sporadic enterovirus and adenovirus infections. J Clin Virol 1999; 12: 211-9
44. Shattuck KE, Chonmaitree T. The changing spectrum of neonatal meningitis over a fifteen-year period. Clin Pediatr 1992; 31: 130-6
45. Byington CL, Taggart EW, Carroll KC, et al. A polymerase chain reaction-based epidemiologic investigation of the incidence of nonpolio enteroviral infections in febrile and afebrile infants 90 days and younger. Pediatrics 1999; 103: E27
46. Rotbart HA, McCracken GH, Whitley RJ, et al. Clinical significance of enteroviruses in serious summer febrile illnesses of children. Pediatr Infect Dis J 1999; 18: 869-74
47. Horn P. Poliomyelitis in pregnancy: a twenty-year report from Los Angeles County, California. J Am Acad Obstet Gynecol 1905; 6: 121-37
48. Jones MJ, Kolb M, Votava HJ, et al. Intrauterine echovirus type 11 infection. Mayo Clin Proc 1980; 55: 509-12
49. Amstey MS, Miller RK, Menegus MA, et al. Enterovirus in pregnant women and the perfused placenta. Am J Obstet Gynecol 1988; 158: 775-82
50. Reyes MP, Ostrea EM, Roskamp J, et al. Disseminated neonatal echovirus 11 disease following antenatal maternal infection with a virus-positive cervix and virus-negative gastrointestinal tract. J Med Virol 1983; 12: 155-9
51. Reyes MP, Zalenski D, Smith F, et al. Coxsackievirus-positive cervices in women with febrile illnesses during the third trimester in pregnancy. Am J Obstet Gynecol 1986; 155: 159-61
52. Burch GE, Sun SC, Chu KC, et al. Interstitial and coxsackievirus B myocarditis in infants and children. JAMA 1968; 203: 1-8
53. Strong BS, Young SA. Intrauterine coxsackievirus, group B type 1, infection: viral cultivation from anmiotic fluid in the third trimester. Am J Perinatol 1995; 55: 509-12
54. Philip AGS, Larson EJ. Overwhelming neonatal infection with ECHO 19 virus. J Pediatr 1973; 82: 391-7
55. Berkovich S, Smithwick EM. Transplacental infection due to ECHO virus type 22. J Pediatr 1968; 72: 94-6
56. Garcia AGP, Basso NGDS, Fonseca MEF, et al. Congenital echo virus infection: morphological and virological study of fetal and placental tissue. J Pathol 1990; 160: 123-7
57. Skeels MR, Williams JJ, Ricker FM. Perinatal echovirus infection [letter]. N Engl J Med 1981; 305: 1529
58. Batcup G, Holt P, Hambling MH, et al. Placental and fetal pathology in coxsackie virus A9 infection: a case report. Histopathology 1985; 9: 1227-35
59. Garcia AGP, Basso NGDS, Fonseca MEF, et al. Enterovirus associated placental morphology: a light, virological, electron microscopic and immunohistologic study. Placenta 1991; 12: 533-47
60. Nielsen JL, Berryman GK, Hankins GDV. Intrauterine fetal death and the isolation of echovirus 27 from amniotic fluid. J Infect Dis 1988; 158: 501-2
61. Brightman VJ, McNair Scott TF, Westphal M, et al. An outbreak of coxsackie B-5 virus infection in a newborn nursery. J Pediatr 1966; 69: 179-92
62. Kinney JS, McCray E, Kaplan JE, et al. Risk factors associated with echovirus 11 infection in a hospital nursery. Pediatr Infect Dis J 1986; 5: 192-7
63. Nagington J, Wreghitt TG, Gandy G, et al. Fatal echovirus 11 infections in outbreak in special-care baby unit. Lancet 1978; 11: 725-8
64. Rabkin CS, Telzak EE, Ho MS, et al. Outbreak of echovirus 11 infection in hospitalized neonates. Pediatr Infect Dis J 1988; 7: 186-90
65. Jankovic B, Pasic S, Kanjuh B, et al. Severe neonatal echovirus 17 infection during a nursery outbreak. Pediatr Infect Dis J 1999; 18: 393-4
66. Pasic S, Jankovic B, Abinun M, et al. Intravenous immunoglobulin prophylaxis in an echovirus 6 and echovirus 4 nursery outbreak. Pediatr Infect Dis J 1997; 16: 718-20
67. Modlin JF, Polk BF, Horton P, et al. Perinatal echovirus infection: risk of transmission during a community outbreak. N Engl J Med 1981; 305: 368-71
68. Lonnrot M, Knip M, Roivainen M, et al. Onset of type 1 diabetes mellitus in infancy after enterovirus infections. Diabet Med 1998; 15: 431-4
69. Abzug MJ, Keyserling HL, Lee ML, et al. Neonatal enterovirus infection: virology, serology, and effects of intravenous immune globulin. Clin Infect Dis 1995; 20: 1201-6
70. Sawada T, Kohno Y, Ikegami H, et al. Detection of coxsackie B2 virus myocarditis in a neonate using TI-201 and I-123 BMIPP myocardial imaging. Clin Nucl Med 2000 Jan; 25: 77-8
71. Dagan R, Jenista JA, Prather SL, et al. Viremia in hospitalized children with enterovirus infections. J Pediatr 1985; 106: 397-401
72. Dahlquist GG, Boman JE, Juto P. Enteroviral RNA and IgM antibodies in early pregnancy and risk for childhood-onset IDDM in offspring. Diabetes Care 1999; 22: 364-5
73. Terletskaia-Ladwig E, Metzger C, Schalasta G, et al. Evaluation of enterovirus serological tests IgM-EIA and complement fixation in patients with meningitis, confirmed by detection of enteroviral RNA by RT-PCR in cerebrospinal fluid. J Med Virol 2000; 61: 221-7
74. Terletskaia-Ladwig E, Metzger C, Schalasta G, et al. A new enzyme immunoassay for the detection of enteroviruses in faecal specimens. J Med Virol 2000; 60: 439-45
75. Bourlet T, Gharbi J, Omar S, et al. Comparison of a rapid culture method combining an immunoperoxidase test and a group specific anti-VPI monoclonal antibody with conventional virus isolation techniques for routine detection of enteroviruses in stools. J Med Virol 1998; 54: 204-9
76. Rotbart HA. Diagnosis of enteroviral meningitis with the polymerase chain reaction. J Pediatr 1990; 117: 85-9
77. Sawyer MH, Holland D, Aintablian N, et al. Diagnosis of enteroviral central nervous system infection by polymerase chain reaction during a large community outbreak. Pediatr Infect Dis J 1994; 13: 177-82
78. Rotbart HA, Ahmed A, Hickey S, et al. Diagnosis of enterovirus infection by polymerase chain reaction of multiple specimen types. Pediatr Infect Dis J 1997; 16: 409-11
79. Ahmed A, Brito F, Goto C, et al. Clinical utility of the polymerase chain reaction for diagnosis of enteroviral meningitis in infancy. J Pediatr 1997; 131: 393-7
80. Schlessinger Y, Sawyer MH, Storch GA. Enteroviral meningitis in infancy: potential role for polymerase chain reaction in patient management. Pediatrics 1994; 94: 157-62
81. Rice SK, Heinl RE, Thornton LL, et al. Clinical characteristics, management strategies, and cost implications of a statewide outbreak of enterovirus meningitis. Clin Infect Dis 1995; 20: 931-7
82. Romero JR, Hinrich SH, Cavalieri SJ, et al. Potential health care cost savings from PCR-based rapid diagnosis of enteroviral meningitis [abstract]. Pediatr Res 1996; 39: 139A
83. Abzug MJ, Loeffelholz M, Rotbart HA. Diagnosis of neonatal enterovirus infection by polymerase chain reaction. J Pediatr 1995; 26: 447-50
84. Yoshio H, Yamada M, Yokoi Y, et al. Diagnosis of neonatal enterovirus meningitis by reverse transcription-polymerase chain reaction. Kansenshogaku Zasshi 1997; 71: 1046-50
85. Chambon M, Delage C, Bailly JL, et al. Fatal hepatic necrosis in a neonate with echovirus 20 infection: use of the polymerase chain reaction to detect enterovirus in liver tissue. Clin Infect Dis 1997; 24: 523-4
86. Austin BJ, Croxson MC, Powell KF, et al. The successful containment of coxsackie B4 infection in a neonatal unit. J Paediatr Child Health 1999; 35: 102-4
87. Chambon M, Bailly JL, Beguet A, et al. An outbreak due to echovirus type 30 in a neonatal unit in France in 1997: usefulness of PCR diagnosis. J Hosp Infect 1999; 43: 63-8
88. Takami T, Kawashima H, Takei Y, et al. Usefulness of nested PCR and sequence analysis in a nosocomial outbreak of neonatal enterovirus infection. J Clin Virol 1998; 11: 67-75
89. Bailly J, Beguet A, Chambon M, et al. Nosocomial transmission of echovirus 30: molecular evidence by phylogenetic analysis of the VPI encoding sequence. J Clin Microbiol 2000; 38: 2889-92
90. Takami T, Sonodat S, Houjyo H, et al. Diagnosis of horizontal enterovirus infections in neonates by nested PCR and direct sequence analysis. J Hosp Infect 2000; 45: 283-7
91. Syriopoulou VP, Hadjichristodoulou CH, Daikos GL, et al. Clinical and epidemiological aspects of an enterovirus outbreak in a neonatal unit. J Hosp Infect 2002; 51: 275-80
92. Isacsohn M, Eidelman AI, Kaplan M, et al. Neonatal coxsackievirus group B infections: experience of a single department of neonatology. Isr J Med Sci 1994; 30: 371-4
93. Clavell M, Barkemeyer B, Martinez B, et al. Severe hepatitis in a newborn with coxsackievirus B5 infection. Clin Pediatr 1999; 38: 739-41
94. Chuang E, Maller ES, Hoffman MA, et al. Successful treatment of fulminant echovirus 11 infection in a neonate by orthotopic liver transplantation. J Pediatr Gastroenterol Nutr 1993; 17: 211-4
95. Van Saene HKF, Stoutenbeek CP, Faber-Nijholt R, et al. Selective decontamination of the digestive tract contributes to the control of disseminated intravascular coagulation in severe liver impairment. J Pediatr Gastroenterol Nutr 1986; 5: 476-80
96. Gilliam GL, Stokes KB, McLellan J, et al. Fulminant hepatic failure with intractable ascites due to an echovirus 11 infection successfully managed with a peritoneo-venous (LeVeen) shunt. J Pediatr Gastroenterol Nutr 1986; 5: 476-80
97. Nagington J. Echovirus 11 infection and prophylactic antiserum [letter]. Lancet 1982; 11: 446
98. Dagan R, Prather S, Powell K, et al. Neutralizing antibodies to non-polio enteroviruses in human immune serum globulin. Pediatr Infect Dis J 1983; 2: 454-6
99. Hammond GW, Lukes H, Wells B, et al. Maternal and neonatal neutralizing antibody titers to selected enteroviruses. Pediatr Infect Dis J 1985; 4: 32-5
100. Wong SN, Tam AYC, Ng TH, et al. Fatal coxsackie B1 virus infection in neonates. Pediatr Infect Dis J 1989; 8: 638-41
101. Black S. Treatment of overwhelming neonatal ECHO 5 virus infection with intravenous gamma globulin [abstract no. 314]. In: American Society for Microbiology: program and abstracts of the 23rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington (DC): American Society for Microbiology, 1983: 140
102. Johnston JM, Overall JC. Intravenous immunoglobulin in disseminated neonatal echovirus 11 infection. Pediatr Infect Dis J 1989; 8: 254-6
103. Valduss D, Murray DL, Karna P. Use of intravenous immunoglobulin in twin neonates with disseminated coxsackie B1 infection. Clin Pediatr 1993; 32: 561-3
104. Kimura H, Minakami H, Harigaya A, et al. Treatment of neonatal infection caused by coxsackievirus B3. J Perinatol 1999; 19: 388-90
105. Jantausch BA, Luban NL, Duffy L, et al. Maternal plasma transfusion in the treatment of disseminated neonatal echovirus 11 infection. Pediatr Infect Dis J 1995; 14: 154-5
106. Rotbart HA. Antiviral therapy for enteroviral infections. Pediatr Infect Dis J 1999; 18: 632-3
107. Sawyer MH. Enterovirus infections: diagnosis and treatment. Pediatr Infect Dis J 1999 Dec; 18: 1033-40
108. Groarke JM, Pevear DC. Attenuated virulence of pleconaril-resistant coxsackievirus B3 variants. J Infect Dis 1999; 179: 1538-41
109. Pevear DC, Tull TM, Seipel ME. Activity of pleconaril against enteroviruses. Antimicrob Agents Chemother 1999; 43: 2109-15
110. Schiff GM, Sherwood JR. Clinical activity of pleconaril in an experimentally induced coxsackievirus A21 respiratory infection. J Infect Dis 2000; 181: 20-6
111. Shafran SD, Halota W, Gilbert D, et al. Pleconaril is effective for enteroviral meningitis in adolescents and adults: a randomized placebo-controlled multicenter trial [abstract no. 1904]. In: American Society for Microbiology: programs and abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington (DC): American Society for Microbiology, 1999: 436
112. Beer K, ViroPharma Inc. ViroPharma announces results of viral respiratory infection and viral meningitis studies [online]. Available from URL: http:// www.viropharma.com/index.htm [Accessed 2002 Dec 31]
113. Sawyer MH, Saez-Llorenz X, Aviles CL, et al. Oral pleconaril reduces the duration and severity of enterovirus meningitis in children [abstract no. 1012]. Pediatr Res 1999 Apr; 45 (4): 173A
114. Beer K, ViroPharma Inc. ViroPharma Incorporated announces successful viral respiratory infection program with pleconaril [online]. Available from URL: http://www.viropharma.com/index.htm [Accessed 2002 Dec 31]
115. Beer K, ViroPharma Inc. Picovir™ (pleconaril) is first antiviral drug candidate shown in pivotal studies to treat the cause and symptoms of viral respiratory infection [online]. Available from URL: http: //www.viropharma.com/index.htm [Accessed 2002 Dec 31]
116. Rotbart HA, Webster AD. Treatment of potentially life-threatening enterovirus infections with pleconaril. Clin Infect Dis 2001; 32: 228-35
117. Abzug MJ, Cloud G, Bradley J, et al. Double-blind, placebo-controlled trial of pleconaril in infants with enterovirus meningitis. Pediatr Infect Dis J 2003 Apr; 22: 335-40
118. Kearns GL, Bradley JS, Jacobs RJ, et al. Single dose pharmacokinetics of pleconaril in neonates. Pediatr Infect Dis J 2000; 19: 833-9
119. Bauer S, Gottesman G, Sirota L, et al. Severe coxsackie virus B infection in preterm newborns treated with pleconaril. Eur J Pediatr 2002; 161: 491-3
120. Aradottir E, Alonso EM, Shulman ST. Severe neonatal enteroviral hepatitis treated with pleconaril. Pediatr Infect Dis 2001 Apr; 20: 457-9
121. Beer K, ViroPharma Inc. ViroPharma provides further update on Picovir™ NDA [online]. Available from URL: http://www.viropharma.com/index.htm [Accessed 2002 Dec 31]
122. Wilson CW, Stevenson DK, Arvin AM. A concurrent epidemic of respiratory syncytial virus and echovirus 7 infections in an intensive care nursery. Pediatr Infect Dis J 1989; 8: 24-9
123. Carolane DJ, Long AM, McKeever PA, et al. Prevention of spread of echovirus 6 in a special care baby unit. Arch Dis Child 1985; 60: 674-6
124. Nagington J, Walker J, Gandy G. Use of normal immunoglobulin in an echovirus 11 outbreak in a special-care baby unit. Lancet 1983; 11: 443-6